Evaluation of efficacy and safety of Evolocumab 140 mg in genetically characterized He-FH patients. First experience of Genoa lipid clinic

Nutrition, Metabolism and Cardiovascular Diseases(2017)

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要